FREE SHIPPING over $40
OVER 9000 FIVE-STAR REVIEWS
5% OFF ALL SUBSCRIPTIONS
100% HAPPINESS GUARANTEE
Analyze Diet
0
Home / Equine Research Bank / Vaccines (Basel) / Equine Vaccines: How, When and Why? Report of the Vaccinolog...
Vaccines2017; 5(4); 46; doi: 10.3390/vaccines5040046

Equine Vaccines: How, When and Why? Report of the Vaccinology Session, French Equine Veterinarians Association, 2016, Reims.

Abstract: To date, vaccination is one of the most efficient methods of prevention against equine infectious diseases. The vaccinology session, which was organised during the annual meeting of the French Equine Veterinarians Association (AVEF) at Reims (France) in 2016, aimed to approach three subjects of importance for the equine industry. Vaccination against three major equine diseases were used as examples: equine influenza (equine influenza virus), rhinopneumonitis (equine herpes virus 1/4), and tetanus ( neuro-toxin). (1) Emergency vaccination: while it has been very successful to reduce the impact of equine influenza epizooties and it is also recommended for tetanus in case of surgery and accident, the benefit of emergency vaccination against equine herpes virus 1/4 remains arguable; (2) Compatibility of equine vaccines from different brands: despite being a frequent concerns for equine veterinarians, little information is available about the compatibility of equine vaccines from different commercial origins. The consequence of mixing different equine vaccines targeting the same disease is believed to be limited but scientific evidences are sparse; and, (3) Laps vaccination and vaccine shortage: they could have serious consequences in terms of protection and their impact should be evaluated on a case by case basis, taking into account the risk of contact with the pathogen and the effect on herd immunity.
Get Full Text
Publication Date: 2017-12-04 PubMed ID: 29207516PubMed Central: PMC5748612DOI: 10.3390/vaccines5040046Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
LinkedInCopy
  • Congress

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

The research article discusses the efficacy and considerations in using vaccines as a preventive method against equine infectious diseases. The paper specifically focuses on vaccinations against equine influenza, rhinopneumonitis, and tetanus. It tackles issues related to emergency vaccination, vaccine compatibility, and the implications of lapses in vaccination or vaccine shortages.

Emergency Vaccination

  • The paper explores the value of emergency vaccination in reducing the effects of equine diseases, using equine influenza, rhinopneumonitis, and tetanus as case studies.
  • Emergency vaccination has shown substantial success in minimizing the impact of equine influenza and is advisable for tetanus in emergency situations such as surgeries or accidents.
  • The effectiveness of emergency vaccination against equine herpes virus 1/4, though, is still under debate. The paper indicates that more research is needed to establish its benefits conclusively.

Compatibility of Equine Vaccines

  • Another major point discussed is the compatibility of vaccines from different brands. This is a common concern among equine veterinarians because often, little information is available about the inter-brand compatibility of vaccines.
  • The paper notes that the effects of using different equine vaccines that target the same disease are believed to be minimal. However, it highlights that there is a lack of robust scientific evidence in this area.

Vaccination Lapses and Vaccine Shortages

  • The paper also delves into the potential consequences of vaccination lapses and vaccine shortages. Such situations could significantly impact the level of protection offered to the horses and influence herd immunity.
  • These impacts should be assessed on a case-by-case basis, factoring in the likelihood of the animal coming into contact with the pathogen and the consequent effects on the entire herd’s immunity.

Cite This Article

APA
Paillot R, Marcillaud Pitel C, D'Ablon X, Pronost S. (2017). Equine Vaccines: How, When and Why? Report of the Vaccinology Session, French Equine Veterinarians Association, 2016, Reims. Vaccines (Basel), 5(4), 46. https://doi.org/10.3390/vaccines5040046

Publication

Vaccines
ISSN: 2076-393X
NlmUniqueID: 101629355
Country: Switzerland
Language: English
Volume: 5
Issue: 4
PII: 46

Researcher Affiliations

Paillot, Romain
  • Animal Health Trust (AHT), Lanwades Park, Kentford, Newmarket, Suffolk CB8 7UU, UK. romain.paillot@aht.org.uk.
  • BIOTARGEN EA 7450, Normandie Université, UNICAEN-LABÉO, 14280 Saint Contest, France. romain.paillot@aht.org.uk.
Marcillaud Pitel, Christel
  • RESPE (Réseau d'Epidémio-Surveillance en Pathologie Équine), 14280 Saint Contest, France. c.marcillaud-pitel@respe.net.
D'Ablon, Xavier
  • RESPE (Réseau d'Epidémio-Surveillance en Pathologie Équine), 14280 Saint Contest, France. xavier.d-ablon@wanadoo.fr.
  • Clinique Vétérinaire de la Côte Fleurie, Route de Paris-Bonneville sur Touques, 14800 Deauville, France. xavier.d-ablon@wanadoo.fr.
Pronost, Stéphane
  • BIOTARGEN EA 7450, Normandie Université, UNICAEN-LABÉO, 14280 Saint Contest, France. stephane.pronost@laboratoire-labeo.fr.

Conflict of Interest Statement

The authors declare no conflict of interest.

References

This article includes 37 references
  1. British Horseracing Authority. Economic Impact of British Racing, 2013. British Horseracing Authority; London, UK: 2013.
  2. Vial C, Bigot G, Heydemann P, Cordilhac C. Les chiffres clés de la filière équine à l’international: Un essai de collecte d’informations. Equ'idée 2017.
  3. Paillot R, El-Hage CM. The Use of a Recombinant Canarypox-Based Equine Influenza Vaccine during the 2007 Australian Outbreak: A Systematic Review and Summary.. Pathogens 2016 Jun 10;5(2).
    doi: 10.3390/pathogens5020042pmc: PMC4931393pubmed: 27294963google scholar: lookup
  4. Callinan I. Equine Influenza, the August 2007 Outbreak in Australia. .
  5. Moloney BJ. Overview of the epidemiology of equine influenza in the Australian outbreak.. Aust Vet J 2011 Jul;89 Suppl 1:50-6.
    doi: 10.1111/j.1751-0813.2011.00748.xpubmed: 21711290google scholar: lookup
  6. Guthrie AJ. Equine Influenza in South Africa 2003 Outbreak. Proceedings of the 9th International Congress of World Equine Veterinary Association Marrakech, Morocco. 22–26 January 2006; Marrakech, Morocco: World Equine Veterinary Association; 2006.
  7. Garner MG, Cowled B, East IJ, Moloney BJ, Kung N. Evaluating the effectiveness of the response to equine influenza in the Australian outbreak and the potential role of early vaccination.. Aust Vet J 2011 Jul;89 Suppl 1:143-5.
    doi: 10.1111/j.1751-0813.2011.00769.xpubmed: 21711314google scholar: lookup
  8. Garner MG, Cowled B, East IJ, Moloney BJ, Kung NY. Evaluating the effectiveness of early vaccination in the control and eradication of equine influenza--a modelling approach.. Prev Vet Med 2011 Apr 1;99(1):15-27.
    doi: 10.1016/j.prevetmed.2010.02.007pubmed: 20236718google scholar: lookup
  9. May T. Vaccines as community-focused therapy.. Expert Rev Vaccines 2003 Jun;2(3):341-3.
    doi: 10.1586/14760584.2.3.341pubmed: 12903800google scholar: lookup
  10. Major DA, Jones B. Behaviour of equine influenza virus in a naïve population: a practitioner's perspective.. Aust Vet J 2011 Jul;89 Suppl 1:13-4.
    doi: 10.1111/j.1751-0813.2011.00726.xpubmed: 21711271google scholar: lookup
  11. Kannegieter NJ, Frogley A, Crispe E, Kirkland PD. Clinical outcomes and virology of equine influenza in a naïve population and in horses infected soon after receiving one dose of vaccine.. Aust Vet J 2011 Jul;89 Suppl 1:139-42.
    doi: 10.1111/j.1751-0813.2011.00768.xpubmed: 21711313google scholar: lookup
  12. Galvin P, Gildea S, Arkins S, Walsh C, Cullinane A. The evaluation of a nucleoprotein ELISA for the detection of equine influenza antibodies and the differentiation of infected from vaccinated horses (DIVA).. Influenza Other Respir Viruses 2013 Dec;7 Suppl 4(Suppl 4):73-80.
    doi: 10.1111/irv.12195pmc: PMC5655885pubmed: 24224822google scholar: lookup
  13. Paillot R. Vaccination contre l’herpèsvirus équin 1. Pratique Vétérinaire Equine 2012;44:15–23.
  14. Paillot R, Case R, Ross J, Newton JR, Nugent J. Equine herpes virus-1: Virus, immunity and vaccines. Open Vet. Sci. J. 2008;2:68–91.
    doi: 10.2174/1874318808002010068google scholar: lookup
  15. HBLB Horserace Betting Levy Board (HBLB). HBLB Horserace Betting Levy Board (HBLB) Codes of Practice 2017, Equine Herpesvirus-EHV. .
  16. Lunn DP, Davis-Poynter N, Flaminio MJ, Horohov DW, Osterrieder K, Pusterla N, Townsend HG. Equine herpesvirus-1 consensus statement.. J Vet Intern Med 2009 May-Jun;23(3):450-61.
    doi: 10.1111/j.1939-1676.2009.0304.xpubmed: 19645832google scholar: lookup
  17. Ivens P. EHM—What every equine practitioner needs to know. Livestock 2014;19:180–185.
    doi: 10.12968/live.2014.19.3.180google scholar: lookup
  18. Henninger RW, Reed SM, Saville WJ, Allen GP, Hass GF, Kohn CW, Sofaly C. Outbreak of neurologic disease caused by equine herpesvirus-1 at a university equestrian center.. J Vet Intern Med 2007 Jan-Feb;21(1):157-65.
    doi: 10.1111/j.1939-1676.2007.tb02942.xpubmed: 17338164google scholar: lookup
  19. Kydd JH, Slater J, Osterrieder N, Lunn DP, Antczak DF, Azab W, Balasuriya U, Barnett C, Brosnahan M, Cook C, Damiani A, Elton D, Frampton A, Gilkerson J, Goehring L, Horohov D, Maxwell L, Minke J, Morley P, Nauwynck H, Newton R, Perkins G, Pusterla N, Soboll-Hussey G, Traub-Dargatz J, Townsend H, Van de Walle GR, Wagner B. Third International Havemeyer Workshop on Equine Herpesvirus type 1.. Equine Vet J 2012 Sep;44(5):513-7.
    doi: 10.1111/j.2042-3306.2012.00604.xpubmed: 22888774google scholar: lookup
  20. AAEP American Association of Equine Practitioners (AAEP). AAEP American Association of Equine Practitioners (AAEP) Equine Herpes (EHV) Control Guidelines. .
  21. Rash A, Morton R, Woodward A, Maes O, McCauley J, Bryant N, Elton D. Evolution and Divergence of H3N8 Equine Influenza Viruses Circulating in the United Kingdom from 2013 to 2015.. Pathogens 2017 Feb 8;6(1).
    doi: 10.3390/pathogens6010006pmc: PMC5371894pubmed: 28208721google scholar: lookup
  22. Fougerolle S, Legrand L, Lecouturier F, Sailleau C, Paillot R, Hans A, Pronost S. Genetic evolution of equine influenza virus strains (H3N8) isolated in France from 1967 to 2015 and the implications of several potential pathogenic factors.. Virology 2017 May;505:210-217.
    doi: 10.1016/j.virol.2017.02.003pubmed: 28292661google scholar: lookup
  23. Paillot R, Hannant D, Kydd JH, Daly JM. Vaccination against equine influenza: quid novi?. Vaccine 2006 May 8;24(19):4047-61.
    doi: 10.1016/j.vaccine.2006.02.030pubmed: 16545507google scholar: lookup
  24. Paillot R. A Systematic Review of Recent Advances in Equine Influenza Vaccination.. Vaccines (Basel) 2014 Nov 14;2(4):797-831.
    doi: 10.3390/vaccines2040797pmc: PMC4494246pubmed: 26344892google scholar: lookup
  25. Van de Zande S. Prime-Boost Vaccine for the Protection of Equine Viral Infection. World Intellectual Property Organisation; Geneva, Switzerland: 2007.
  26. Barquero N, Daly JM, Newton JR. Risk factors for influenza infection in vaccinated racehorses: lessons from an outbreak in Newmarket, UK in 2003.. Vaccine 2007 Oct 23;25(43):7520-9.
    doi: 10.1016/j.vaccine.2007.08.038pubmed: 17889409google scholar: lookup
  27. Paillot R, Parizot V, Garrett D, Birand I, Lopez-Alvarez MR, Horspool L, Hurley M. Large scale sero-epidemiological investigation of equine influenza vaccination in Hong Kong. Equine Vet. J. 2016;39.
    doi: 10.1016/j.jevs.2016.02.154google scholar: lookup
  28. Nugent J, Birch-Machin I, Smith KC, Mumford JA, Swann Z, Newton JR, Bowden RJ, Allen GP, Davis-Poynter N. Analysis of equid herpesvirus 1 strain variation reveals a point mutation of the DNA polymerase strongly associated with neuropathogenic versus nonneuropathogenic disease outbreaks.. J Virol 2006 Apr;80(8):4047-60.
    doi: 10.1128/JVI.80.8.4047-4060.2006pmc: PMC1440451pubmed: 16571821google scholar: lookup
  29. Cullinane A, Gildea S, Weldon E. Comparison of primary vaccination regimes for equine influenza: working towards an evidence-based regime.. Equine Vet J 2014 Nov;46(6):669-73.
    doi: 10.1111/evj.12214pubmed: 24237177google scholar: lookup
  30. Gildea S, Arkins S, Walsh C, Cullinane A. A comparison of antibody responses to commercial equine influenza vaccines following annual booster vaccination of National Hunt horses - a randomised blind study.. Vaccine 2011 May 17;29(22):3917-22.
    doi: 10.1016/j.vaccine.2011.03.003pubmed: 21419776google scholar: lookup
  31. Gildea S, Arkins S, Walsh C, Cullinane A. A comparison of antibody responses to commercial equine influenza vaccines following primary vaccination of Thoroughbred weanlings--a randomised blind study.. Vaccine 2011 Nov 15;29(49):9214-23.
    doi: 10.1016/j.vaccine.2011.09.101pubmed: 21983355google scholar: lookup
  32. Paillot R, Fraser S, Prowse-Davis L, Rash N, Montesso F, Slootmans N, Thomas A, Besognet B, Meinert T, Ons E. Iscom-based equine influenza vaccine: Duration of immunity and randomised clinical trials to assess an accelerated schedule of immunisation and efficacy. Trials Vaccinol. 2015;4:61–70.
    doi: 10.1016/j.trivac.2015.07.002google scholar: lookup
  33. Paillot R, Prowse L, Donald C, Medcalf E, Montesso F, Bryant N, Watson J, Jeggo M, Elton D, Newton R, Trail P, Barnes H. Efficacy of a whole inactivated EI vaccine against a recent EIV outbreak isolate and comparative detection of virus shedding.. Vet Immunol Immunopathol 2010 Aug 15;136(3-4):272-83.
    doi: 10.1016/j.vetimm.2010.03.019pubmed: 20400185google scholar: lookup
  34. Paillot R, Prowse L. ISCOM-matrix-based equine influenza (EIV) vaccine stimulates cell-mediated immunity in the horse.. Vet Immunol Immunopathol 2012 Jan 15;145(1-2):516-21.
    doi: 10.1016/j.vetimm.2011.11.019pubmed: 22178272google scholar: lookup
  35. Paillot R, Prowse L, Montesso F, Huang CM, Barnes H, Escala J. Whole inactivated equine influenza vaccine: Efficacy against a representative clade 2 equine influenza virus, IFNgamma synthesis and duration of humoral immunity.. Vet Microbiol 2013 Mar 23;162(2-4):396-407.
    doi: 10.1016/j.vetmic.2012.10.019pubmed: 23146168google scholar: lookup
  36. Heldens JG, van Loon AA, van de Zande S. Is there a benefit from an early booster vaccination in the control of equine influenza?. Vet J 2007 Nov;174(3):592-8.
    doi: 10.1016/j.tvjl.2007.03.004pubmed: 17560150google scholar: lookup
  37. Fougerolle S, Legrand L, Garrett D, Birand I, Foursin M, D'Ablon X, Bayssat P, Newton RJ, Pronost S, Paillot R. Influential factors inducing suboptimal humoral response to vector-based influenza immunisation in Thoroughbred foals.. Vaccine 2016 Jul 19;34(33):3787-95.
    doi: 10.1016/j.vaccine.2016.05.068pubmed: 27269055google scholar: lookup

Citations

This article has been cited 10 times.
Subscribe to our newsletter
Join 99,344 horse owners like you who receive our email updates on horse health and nutrition.